Endemic Burkitt Lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility

Affiliations

• ¹ Center for Research on Genomics & Global Health, NHGRI, National Institutes of Health, Bethesda, MD, USA.
• ² EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
• ³ EMBLEM Study, St. Mary's Hospital, Lacor, Gulu, Uganda.
• ⁴ Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
• ⁵ Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
• ⁶ Department of Pathology, The Ohio State University, Columbus, OH, USA.
• ⁷ Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
• ⁸ EMBLEM Study, Kuluva Hospital, Arua, Uganda.
• ⁹ EMBLEM Study, Shirati Health, Education, and Development Foundation, Shirati, Tanzania.
• ¹⁰ Inter-Church Medical Assistance Mission, Baltimore, MD, USA.
• ¹¹ Max von Pettenkofer Institute, LMU University of München, München, Germany.
• ¹² Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.
• ¹³ International Network for Cancer Treatment, Brussels, Belgium.
• ¹⁴ Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.
• ¹⁵ Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA. mbulaits@mail.nih.gov.